Identification and Validation of Alternative Splicing Isoforms as Novel Biomarker Candidates in Hepatocellular Carcinoma

Oncology Reports - Greece
doi 10.3892/or.2018.6947
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Identification of CELSR2 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Correction To: Identification of Novel Human RANK Isoforms Generated Through Alternative Splicing. Implications in Breast Cancer Cell Survival and Migration

Breast Cancer Research
Cancer ResearchOncology
2018English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

CD24 as a Novel Predictive Biomarker in Patients With Hepatocellular Carcinoma: Friend or Foe?

Journal of Investigative Surgery
Surgery
2018English

Exosomal miR-665 as a Novel Minimally Invasive Biomarker for Hepatocellular Carcinoma Diagnosis and Prognosis

Oncotarget
Oncology
2017English

Identification of PA28β as a Potential Novel Biomarker in Human Esophageal Squamous Cell Carcinoma

Tumor Biology
MedicineCancer Research
2017English

Novel IL-15 Isoforms Generated by Alternative Splicing Are Expressed in the Intestinal Epithelium

Genes and Immunity
ImmunologyGenetics
2006English

MBNL1 Alternative Splicing Isoforms Play Opposing Roles in Cancer

Life Science Alliance
Plant ScienceEcologyGeneticsMolecular BiologyBiochemistryMutagenesisHealthToxicology
2018English

Updated Study on Action Mechanisms of Cereblon as a Novel Prognostic Biomarker for Hepatocellular Carcinoma

HPB
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy